Skip to main content

Table 4 Care plan completion time stratified by Clinico-pathologic parameters

From: Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach

Variable Completed in ≤10 min (N = 18) N (%) Completed in > 10 min (N = 23) N (%) Chi-square p-Value
Patient Age
 ≤ 65 Years 2 (14.3%) 8 (42.1%) 2.83 .959
 > 65 Years 12 (85.7%) 11 (57.9%)
Patient Gender
 Male 12 (75%) 12 (66.7%) 2.38 .595
 Female 4 (25%) 6 (33.3%)
Race
 White 17 (94.4%) 20 (90.9%) 1.78 .673
 Other 1 (5.6%) 2 (9.1%)
Insurance Type
 Medicare 9 (52.9%) 10 (47.6%) 1.06 .744
 Other 8 (47.1%) 11 (52.4%)
Disease Stage2
 NMIBC 4 (23.5%) 8 (36.4%) 2.94 .086
 MIBC 19 (76.5%) 14 (63.6%)
Clinic Visits
 ≤ 4 visits 8 (47.0%) 15 (71.4%) 1.99 .656
 ≥ 5 visits 9 (53.0%) 6 (28.6%)
Provider Type
 Urologist 13 (72.2%) 17 (73.9%) 2.968 .397
 Medical Oncologist 3 (16.7%) 2 (8.7%)
 Other 2 (11.1%) 4 (17.4%)
Years in Practice
 ≤10 Years 3 (33.3%) 6 (60%) .533 .766
 11–19 Years 3 (33.3%) 2 (20%)
 ≥20 Years 3 (33.3%) 2 (20%)